A drug discovery company pairing custom high-throughput chemistry hardware with AI to design better small-molecule medicines.
Terray Therapeutics
Released February 12, 2026
Protein-ligand foundation model that maps coarse-grained structural representations directly to binding affinity, running ~26x faster than Boltz-2.